We are live on ! Find out more
VIR icon

Vir Biotechnology
VIR

143 hedge funds and large institutions have $2.11B invested in Vir Biotechnology in 2020 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 25 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 25

114% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 21

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

20% more funds holding

Funds holding: 119 → 143 (+24)

6.82% more ownership

Funds ownership: 55.14% → 61.95% (+6.8%)

12% less capital invested

Capital invested by funds: $2.41B → $2.11B (-$293M)

23% less call options, than puts

Call options by funds: $10.9M | Put options by funds: $14.3M

Holders
143
Holders Change
+24
Holders Change %
+20.17%
% of All Funds
2.53%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
45
Increased
55
Reduced
25
Closed
21
Calls
$10.9M
Puts
$14.3M
Net Calls
-$3.34M
Net Calls Change
-$3.42M

Top Buyers

1
State Street
State Street
Massachusetts
+$65.2M
2
BlackRock
BlackRock
New York
+$44.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$28.8M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
+$11.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$10.9M

Top Sellers

1
CCP
Clough Capital Partners
Massachusetts
-$6.85M
2
UBS AM
UBS AM
Illinois
-$3.84M
3
N
Nuveen
North Carolina
-$3.11M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$2.95M
5
Norges Bank
Norges Bank
Norway
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank Julius Baer & Co
26
Bank Julius Baer & Co
Switzerland
$3.93M +$3.83M +117,945 +409%
JP Morgan Chase
27
JP Morgan Chase
New York
$3.89M +$903K +27,775 +24%
ERSOT
28
Employees Retirement System of Texas
Texas
$3.27M +$3.97M +122,000 New
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$3.18M -$74.8K -2,300 -2%
Millennium Management
30
Millennium Management
New York
$2.83M +$3.43M +105,679 New
Wells Fargo
31
Wells Fargo
California
$2.68M +$1.91M +58,771 +142%
Morgan Stanley
32
Morgan Stanley
New York
$2.53M +$1.74M +53,525 +131%
CII
33
Capital International Inc
California
$2.23M +$118K +3,634 +5%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$2.17M +$2.67K +82 +0.1%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$2.02M +$39K +1,200 +2%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$1.94M +$646K +19,878 +38%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$1.75M +$140K +4,307 +7%
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$1.75M +$1.27M +38,960 +147%
EMG
39
ETF Managers Group
New Jersey
$1.75M -$223K -6,847 -10%
CS
40
Credit Suisse
Switzerland
$1.66M +$2.01M +61,836 New
Massachusetts Financial Services
41
Massachusetts Financial Services
Massachusetts
$1.43M +$577K +17,741 +50%
Rafferty Asset Management
42
Rafferty Asset Management
New York
$1.34M +$1.62M +49,983 New
CI
43
Capital International
California
$1.31M – – –
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$1.3M – – –
Russell Investments Group
45
Russell Investments Group
United Kingdom
$1.24M +$398K +12,234 +36%
Bank of America
46
Bank of America
North Carolina
$1.23M +$676K +20,801 +83%
Deutsche Bank
47
Deutsche Bank
Germany
$1.23M +$485K +14,925 +48%
UBS Group
48
UBS Group
Switzerland
$1.22M -$648K -19,930 -30%
MSL
49
Mackay Shields LLC
New York
$1.15M +$267K +8,200 +24%
Vontobel Holding
50
Vontobel Holding
Switzerland
$1.14M +$1.39M +42,711 New
1
2
3 4 5

VIR Hedge Fund Activity: Q4 2020 in Review

143 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Vir Biotechnology (VIR) for Q4 2020, worth a combined $2.11B — down 12% from $2.41B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new VIR positions and 21 closed out — a net gain of 24 holders — while 55 added to existing stakes and 25 trimmed.

The largest buyer was State Street, adding an estimated $65.2M. The largest seller was Clough Capital Partners, exiting entirely with an estimated $6.85M sold.

  • 143 institutional investors held Vir Biotechnology (VIR) as of Q4 2020, up from 119 in Q3 2020.
  • Funds reported $2.11B of Vir Biotechnology stock for Q4 2020, down 12% quarter-over-quarter.
  • 45 funds opened new Vir Biotechnology positions in Q4 2020 and 21 closed out, a net change of +24 holders.
  • The largest Vir Biotechnology buyer in Q4 2020 was State Street, an estimated $65.2M added.
  • The largest Vir Biotechnology seller in Q4 2020 was Clough Capital Partners, an estimated $6.85M sold.

Based on aggregated 13F filings for Q4 2020.